- Report
- March 2025
- 193 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- October 2024
- 185 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 184 Pages
Global
From €4727EUR$4,950USD£3,953GBP
- Report
- October 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- October 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- October 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- April 2024
- 130 Pages
Global
From €5682EUR$5,950USD£4,752GBP
- Report
- January 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- April 2024
- 145 Pages
Global
From €4250EUR$4,450USD£3,554GBP
- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1910EUR$2,000USD£1,597GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1910EUR$2,000USD£1,597GBP
- Report
- October 2024
- 200 Pages
Global
From €3581EUR$3,750USD£2,995GBP
- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- May 2024
- 200 Pages
Global
From €3963EUR$4,150USD£3,314GBP
- Report
- May 2024
- 200 Pages
Global
From €3963EUR$4,150USD£3,314GBP
- Report
- May 2024
- 93 Pages
Global
From €14321EUR$14,995USD£11,976GBP
- Report
- January 2025
- 146 Pages
Global
From €14321EUR$14,995USD£11,976GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1910EUR$2,000USD£1,597GBP

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat.
The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more